Al-Khazragie, Z., Sabri, M., Sabri, L. and Al-Atbi, H. 2026. Integrated in silico and in vitro profiling of newly designed heterocyclic thiazolidinone targeting androgen-independent prostate cancer. Babcock University Medical Journal. 9, 3 (Sep. 2026), 151–162. DOI:https://doi.org/10.38029/babcockuniv.med.j. v9i3.1459.